SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA

被引:0
|
作者
Schlitt, H. J. [1 ]
Nashan, B. [1 ]
Schemmer, P. [1 ]
Pascher, A. [1 ]
Klein, C. G. [1 ]
Neumann, U. [1 ]
Kroeger, I. [2 ]
Wimmer, P. [2 ]
Braun, F. [1 ]
机构
[1] Hephaistos Study Grp, Nurnberg, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
V079
引用
收藏
页码:25 / 25
页数:1
相关论文
共 50 条
  • [31] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    TRANSPLANTATION, 2014, 98 : 80 - 80
  • [32] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 80 - 80
  • [33] Everolimus with Early Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients-12 Month Efficacy and Safety Results from H2304 Study
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 28 - 28
  • [34] EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nevens, F.
    De Carlis, L.
    Metselaar, H.
    Saliba, F.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Fung, J.
    Jiang, H.
    Junge, G.
    De Simone, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S551 - S552
  • [35] Everolimus-Facilitated Reduction of Tacrolimus Maintains Comparable Efficacy and Better Renal Function Versus Standard Tacrolimus in De Novo Liver Transplant Recipients.
    De Simone, P.
    Jones, R.
    Kohli, V.
    Gedaly, R.
    Jeffrey, G.
    Cantisani, G.
    Dong, G.
    Joseph, D.
    Lopez, P.
    Junge, G.
    Nevens, F.
    LIVER TRANSPLANTATION, 2013, 19 : S131 - S131
  • [36] Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D. Y.
    Luan, F. L.
    Peddi, V. R.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (05) : 1358 - 1369
  • [37] Allograft Function after 12 Months with Everolimus Plus Either Tacrolimus or Cyclosporine Compared to a Standard Regimen of Tacrolimus with MPA in De Novo Renal Transplant Recipients: The ATHENA Study.
    Nashan, B.
    Sommerer, C.
    Suwelack, B.
    Dragun, D.
    Witzke, O.
    Hugo, C.
    Kamar, N.
    Merville, P.
    Hauser, A.
    Schenker, P.
    Junge, M.
    Thaiss, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 260 - 260
  • [38] Effect of Everolimus With Low Dose Tacrolimus Vs Mycophenolate With Standard Tacrolimus Regimen in African-American De Novo Renal Transplant Recipients
    Peddi, V.
    Qazi, Y.
    Shaffer, D.
    Luan, F.
    Shihab, F.
    Tomlanovich, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 536 - 536
  • [39] Everolimus and Very Low Exposure of Tacrolimus Provides Good Efficacy in De Novo Renal Transplant Recipients (RTxR) at 12 Months.
    Christiaans, M.
    Langer, R.
    Vitko, S.
    Hene, R.
    Tedesco, H.
    Cassuto, E.
    Rostaing, L.
    Asztalos, L.
    Wiecek, A.
    Henriques, A. C.
    Pascual, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 151 - 151
  • [40] Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial
    De Simone, P.
    Detry, O.
    Kintmalm, G.
    Goss, J.
    McCormick, P.
    Rossi, M.
    Moya, A.
    Lopez, P.
    Junge, G.
    Dong, G.
    Joseph, D.
    Duvoux, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 169 - 170